Know Cancer

forgot password

Effect of Stellate Ganglion Block on Meniere's Disease

Phase 4
30 Years
65 Years
Not Enrolling
Vertigo, Meniere Disease

Thank you

Trial Information

Effect of Stellate Ganglion Block on Meniere's Disease

Ten patients were randomly assigned to receive stellate ganglion block. These ten patients
made up the experimental group. Another ten patients in the control group were assigned to
receiving one dosage of oral medications: 0.25mg of erispan@ (fludiazine) , 25mg cephadol@
(diphenidol), and 200mg kentons@ (tocopherol nicotinate).

Inclusion Criteria:

- patients diagnosed with unilateral Meniere's disease, according to the criteria of
the American Academy of Otolaryngology-Head and Neck Surgery, AAO-HNS (1995)

Exclusion Criteria:

- patients with coagulopathy,

- arrhythmia,

- myocardial ischemia,

- glaucoma,

- pregnant,

- chronic otitis media or externa, and

- past history of middle or inner ear surgery were excluded.

Type of Study:


Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

SP/AP of Electrocochleography

Outcome Description:

SP/AP of ECoG was recorded 2 hours after SGB. to be compared with the SP/AP of ECoG recorded before treatment

Outcome Time Frame:

ECoG was reorded 2 hours after SGB

Safety Issue:


Principal Investigator

Yung-Song Lin, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Chi Mei Medical Hospital


Taiwan: Department of Health

Study ID:




Start Date:

April 2010

Completion Date:

March 2012

Related Keywords:

  • Vertigo
  • Meniere Disease
  • stellate ganglion block.
  • Meniere's disease.
  • electrocochleography.
  • vertigo.
  • hearing impairment.
  • Synovial Cyst
  • Ganglion Cysts
  • Meniere Disease
  • Vertigo
  • Dizziness